by Ellie Lampton | May 8, 2025
BELLEVUE, Wash. – May 8, 2025 – Today, Truveta announced a new era in cancer research with more than 7 million oncology patient journeys spanning more than 100 cancer types, delivering an unprecedented breadth of regulatory grade data to support researchers in...
by Ellie Lampton | Apr 15, 2025
Published in the American Journal of Preventative Medicine, the new study shows that for the first time since its peak in 2022, syphilis incidence has declined, with larger decreases for men and young adults. BELLEVUE, WA — April 9, 2025 — A new study published in the...
by Ellie Lampton | Mar 26, 2025
BELLEVUE, Wash. – March 26, 2025 – Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. The company also announced two new Truveta Studio...
by Ellie Lampton | Feb 13, 2025
Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness studies, replacing clinical trials and registries BELLEVUE, Wash. – February 12, 2025 – Today, Truveta announced the expansion of Truveta Data...
by Ellie Lampton | Jan 31, 2025
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine at University of Pennsylvania BELLEVUE, Wash. – January 31, 2025 – Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor...
